Tvardi Therapeutics, Inc. Annual Return On Equity in % from 2013 to 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Tvardi Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2013 to 2024.
  • Tvardi Therapeutics, Inc. Return On Equity for the quarter ending December 31, 2024 was -756 %, a 519% decline year-over-year.
  • Tvardi Therapeutics, Inc. annual Return On Equity for 2024 was -756 %, a 519% decline from 2023.
  • Tvardi Therapeutics, Inc. annual Return On Equity for 2023 was -122 %, a 169% decline from 2022.
  • Tvardi Therapeutics, Inc. annual Return On Equity for 2022 was -45.5 %, a 11.6% decline from 2021.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 -756 -634 -519% Jan 1, 2024 Dec 31, 2024
2023 -122 -76.6 -169% Jan 1, 2023 Dec 31, 2023
2022 -45.5 -4.73 -11.6% Jan 1, 2022 Dec 31, 2022
2021 -40.7 -45.7 -921% Jan 1, 2021 Dec 31, 2021
2020 4.96 +74.4 Jan 1, 2020 Dec 31, 2020
2019 -69.5 -0.33 -0.48% Jan 1, 2019 Dec 31, 2019
2018 -69.1 +2.57 +3.59% Jan 1, 2018 Dec 31, 2018
2017 -71.7 +4.68 +6.13% Jan 1, 2017 Dec 31, 2017
2016 -76.4 -44.4 -139% Jan 1, 2016 Dec 31, 2016
2015 -32 -1.56 -5.13% Jan 1, 2015 Dec 31, 2015
2014 -30.4 -38 -503% Jan 1, 2014 Dec 31, 2014
2013 7.56 Jan 1, 2013 Dec 31, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.